“…The fixed cells were rehydrated in PBS plus 1% bovine serum albumin (BSA; block) for 30 min at RT and incubated in block containing 0.1% Triton X-100 for 30 min at RT, followed by incubation overnight at 4°C in block containing 1:20 anti-acetylated ␣-tubulin clone 6-11B-1 (␣-Ac-tub) (Sigma-Aldrich, St. Louis, MO) (54) plus one of the following antibodies: 1:20 anti-␣-tubulin clone DM1a (␣-tub; Sigma-Aldrich, St. Louis, MO), 1:50 polyclonal anti-ChR1 (37), 1:50 polyclonal anti-ChR2 (37) (see Fig. S2B in the supplemental material), 1:50 polyclonal anti-EYE2 (41). Cells were washed with block containing 0.05% Tween 20, incubated for 2 h at room temperature in block containing a 1:1,000 dilution of the appropriate Alexa Fluor-conjugated secondary antibody (Invitrogen, Carlsbad, CA), washed thoroughly, and coverslipped with Mowiol mounting medium prepared as follows: 2.4 g Mowiol 4-88 (Calbiochem, EMD Biosciences, Inc., La Jolla, CA) and 6 g of glycerol were combined, 6 ml of water was added, and the solution was stirred at RT for 2 h before the addition of 12 ml of 0.2 M Tris (pH ϭ 8.5), being heated to 50°C for 10 min, and being clarified by centrifugation at 5,000 ϫ g for 15 min.…”